These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 25434924

  • 1. Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer.
    Vassal G, Rousseau R, Blanc P, Moreno L, Bode G, Schwoch S, Schrappe M, Skolnik J, Bergman L, Bradley-Garelik MB, Saha V, Pearson A, Zwierzina H.
    Eur J Cancer; 2015 Jan; 51(2):218-24. PubMed ID: 25434924
    [Abstract] [Full Text] [Related]

  • 2. Implementation of mechanism of action biology-driven early drug development for children with cancer.
    Pearson AD, Herold R, Rousseau R, Copland C, Bradley-Garelik B, Binner D, Capdeville R, Caron H, Carleer J, Chesler L, Geoerger B, Kearns P, Marshall LV, Pfister SM, Schleiermacher G, Skolnik J, Spadoni C, Sterba J, van den Berg H, Uttenreuther-Fischer M, Witt O, Norga K, Vassal G, Members of Working Group 1 of the Paediatric Platform of ACCELERATE.
    Eur J Cancer; 2016 Jul; 62():124-31. PubMed ID: 27258969
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Will children with cancer benefit from the new European Paediatric Medicines Regulation?
    Vassal G.
    Eur J Cancer; 2009 Jun; 45(9):1535-46. PubMed ID: 19419857
    [Abstract] [Full Text] [Related]

  • 10. Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives.
    Seifert G, Budach V, Keilholz U, Wust P, Eggert A, Ghadjar P.
    Radiat Oncol; 2016 Apr 30; 11():65. PubMed ID: 27138749
    [Abstract] [Full Text] [Related]

  • 11. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ, Benowitz SI, Adams S, Aghajanian C, Chang SM, Dreyer ZE, Janne PA, Ko AH, Masters GA, Odenike O, Patel JD, Roth BJ, Samlowski WE, Seidman AD, Tap WD, Temel JS, Von Roenn JH, Kris MG.
    J Clin Oncol; 2012 Jan 01; 30(1):88-109. PubMed ID: 22147736
    [Abstract] [Full Text] [Related]

  • 12. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K.
    Clin Ther; 2014 Feb 01; 36(2):163-77. PubMed ID: 24529288
    [Abstract] [Full Text] [Related]

  • 13. Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium.
    Bautista F, Moreno L, Marshall L, Pearson ADJ, Geoerger B, Paoletti X.
    Eur J Cancer; 2017 Nov 01; 86():275-284. PubMed ID: 29055843
    [Abstract] [Full Text] [Related]

  • 14. Progress review of the European Paediatric Regulatory Framework after six years of implementation.
    Mentzer D.
    Int J Pharm; 2014 Aug 05; 469(2):240-3. PubMed ID: 24613178
    [Abstract] [Full Text] [Related]

  • 15. ACCELERATE - Five years accelerating cancer drug development for children and adolescents.
    Pearson ADJ, Weiner SL, Adamson PC, Karres D, Reaman G, Rousseau R, Blanc P, Norga K, Skolnik J, Kearns P, Scobie N, Barry E, Marshall LV, Knox L, Caron H, Wariabharaj D, Pappo A, DuBois SG, Gore L, Kieran M, Weigel B, Fox E, Nysom K, de Rojas T, Vassal G.
    Eur J Cancer; 2022 May 05; 166():145-164. PubMed ID: 35290915
    [Abstract] [Full Text] [Related]

  • 16. Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma.
    Moreno L, Barone G, DuBois SG, Molenaar J, Fischer M, Schulte J, Eggert A, Schleiermacher G, Speleman F, Chesler L, Geoerger B, Hogarty MD, Irwin MS, Bird N, Blanchard GB, Buckland S, Caron H, Davis S, De Wilde B, Deubzer HE, Dolman E, Eilers M, George RE, George S, Jaroslav Š, Maris JM, Marshall L, Merchant M, Mortimer P, Owens C, Philpott A, Poon E, Shay JW, Tonelli R, Valteau-Couanet D, Vassal G, Park JR, Pearson ADJ.
    Eur J Cancer; 2020 Sep 05; 136():52-68. PubMed ID: 32653773
    [Abstract] [Full Text] [Related]

  • 17. Drug development: EU paediatric legislation, the European Medicines Agency and its Paediatric Committee--adolescents' melanoma as a paradigm.
    Rose K, Senn S.
    Pharm Stat; 2014 Sep 05; 13(4):211-3. PubMed ID: 24903307
    [Abstract] [Full Text] [Related]

  • 18. Changing incentives to ACCELERATE drug development for paediatric cancer.
    de Rojas T, Kearns P, Blanc P, Skolnik J, Fox E, Knox L, Rousseau R, Doz F, Bird N, Pearson AJ, Vassal G.
    Cancer Med; 2023 Apr 05; 12(7):8825-8837. PubMed ID: 36645217
    [Abstract] [Full Text] [Related]

  • 19. The NCI All Ireland Cancer Conference.
    Johnston PG, Daly PA, Liu E.
    Oncologist; 1999 Apr 05; 4(4):275-277. PubMed ID: 10545862
    [Abstract] [Full Text] [Related]

  • 20. The role of the 'innovative therapies for children with cancer' (ITCC) European consortium.
    Zwaan CM, Kearns P, Caron H, Verschuur A, Riccardi R, Boos J, Doz F, Geoerger B, Morland B, Vassal G, 'innovative therapies for children with cancer' European consortium.
    Cancer Treat Rev; 2010 Jun 05; 36(4):328-34. PubMed ID: 20231057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.